NEW YORK (GenomeWeb) - Affymetrix today reported a slight decrease year over year in its third quarter reported revenues.

For the three months ended Sept. 30, Affymetrix's total revenues dipped less than one percent to $86.5 million from $87.1 million in the prior-year period. On a constant currency basis, its revenues increased almost 4 percent year over year, and beat the average Wall Street estimate of $87.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.